Identification of exacerbation markers in chronic inflammatory airway diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00000632

Enrollment

120

Registered

2011-04-04

Start date

2011-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J45 J44

Interventions

Group 1: Patients suffering from chronic inflammatory airway diseases (asthma or COPD) Group 2: Patients suffering from infections of the upper airways, in the absence of a chronic inflammatory airway

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Status of the donor: a) confirmed chronic inflammatory airway disease (asthma or COPD) or b) infection of the upper airways in the absence of a chronic inflammatory airway disease or c) healthy

Exclusion criteria

Exclusion criteria: The patient is not able to give his/her informed consent. The patient is in any relationship of dependency with the participating institutions

Design outcomes

Primary

Measure	Time frame
The composition of airway secretions from healthy individuals and patients suffering from infections of the upper airways or from chronic inflammatory airway diseases is analyzed and compared.	—

Countries

Germany

Contacts

Public ContactAndreas Frey

Forschungszentrum Borstel Laborgruppe Mukosaimmunologie

afrey@fz-borstel.de04537-188562

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026